Managing Sickness Syndrome depression in your patients necessitates the employment of specific treatment strategies to accomplish the following two objectives:

• Modulate the stress response and in particular cortisol production
• Inhibit the production of inflammatory cytokines and/or counter their effects. 

If the physician remains focused on this goal while employing his/her treatment strategy, it will prove to be a significant and beneficial approach to dealing with the depression-stress-inflammatory response link.

The treatment strategies provided for healthcare professionals on this informational Sickness Syndrome site take into account the known biochemical and physiologic pathways affected in patients challenged with Sickness Syndrome depression.

If you are a healthcare professional and would like to print the Self Assessment and provide it to your patients you can then send the completed survey to us for a full analysis. To open a PDF of the Self Assessment click here. The last page of the PDF contains instructions for returning the completed suvey.

The nutraceutical options prescribed to combat the effects of Sickness Syndrome depression have specific properties. While each has key properties specific to its chemical composition, they all share an ability to address Sickness Syndrome symptoms in one or more ways:

• Mediating hypoglycemic actions through cortisol-regulating activity
• Regulating corticosteroid-induced inflammation and insulin resistance
• Inhibiting lipooxygenase, cyclooxygenase 2, leukotriene
• Providing anti-inflammatory and antibacterial benefits

Within this overall classification, the nutraceuticals are subdivided further into several categories by virtue of their primary mechanisms of action.  Click on the Nutraceuticals section to further research this treatment option.